Roger Clarnette

3.0k total citations
48 papers, 2.0k citations indexed

About

Roger Clarnette is a scholar working on Physiology, Psychiatry and Mental health and Geriatrics and Gerontology. According to data from OpenAlex, Roger Clarnette has authored 48 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 16 papers in Psychiatry and Mental health and 12 papers in Geriatrics and Gerontology. Recurrent topics in Roger Clarnette's work include Dementia and Cognitive Impairment Research (15 papers), Alzheimer's disease research and treatments (13 papers) and Frailty in Older Adults (11 papers). Roger Clarnette is often cited by papers focused on Dementia and Cognitive Impairment Research (15 papers), Alzheimer's disease research and treatments (13 papers) and Frailty in Older Adults (11 papers). Roger Clarnette collaborates with scholars based in Australia, United States and Ireland. Roger Clarnette's co-authors include Ralph N. Martins, Osvaldo P. Almeida, David Bruce, Sam Gandy, David Ames, Henry Brodaty, Timothy M. E. Davis, Wendy A. Davis, Kevin Taddei and John Snowdon and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Neurology and Diabetes Care.

In The Last Decade

Roger Clarnette

46 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Clarnette Australia 24 767 682 347 236 212 48 2.0k
Ann Marie Hake United States 27 835 1.1× 738 1.1× 284 0.8× 282 1.2× 250 1.2× 68 2.3k
M.‐X. Tang United States 16 985 1.3× 788 1.2× 297 0.9× 242 1.0× 203 1.0× 27 2.5k
Miranda G. Dik Netherlands 24 922 1.2× 790 1.2× 249 0.7× 193 0.8× 381 1.8× 32 2.7k
Huang Changquan China 23 466 0.6× 468 0.7× 277 0.8× 286 1.2× 226 1.1× 54 2.2k
Olivier Rouaud France 33 1.2k 1.5× 794 1.2× 367 1.1× 360 1.5× 432 2.0× 119 4.2k
Asenath La Rue United States 30 1.5k 2.0× 1.2k 1.7× 207 0.6× 292 1.2× 315 1.5× 68 3.1k
Kornelia Kędziora–Kornatowska Poland 28 365 0.5× 589 0.9× 303 0.9× 407 1.7× 143 0.7× 203 2.8k
Anna Rita Atti Italy 22 534 0.7× 650 1.0× 166 0.5× 167 0.7× 250 1.2× 64 2.3k
Antonio Capurso Italy 24 856 1.1× 833 1.2× 469 1.4× 383 1.6× 335 1.6× 44 2.7k
Zaldy S. Tan United States 20 875 1.1× 720 1.1× 279 0.8× 254 1.1× 298 1.4× 52 2.5k

Countries citing papers authored by Roger Clarnette

Since Specialization
Citations

This map shows the geographic impact of Roger Clarnette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Clarnette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Clarnette more than expected).

Fields of papers citing papers by Roger Clarnette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Clarnette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Clarnette. The network helps show where Roger Clarnette may publish in the future.

Co-authorship network of co-authors of Roger Clarnette

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Clarnette. A scholar is included among the top collaborators of Roger Clarnette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Clarnette. Roger Clarnette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ó’Caoimh, Rónán, et al.. (2019). Selecting a Bedside Cognitive Vital Sign to Monitor Cognition in Hospital: Feasibility, Reliability, and Responsiveness of Logical Memory. International Journal of Environmental Research and Public Health. 16(19). 3545–3545. 2 indexed citations
2.
Ó’Caoimh, Rónán, Nicola Cornally, Ciara McGlade, et al.. (2019). Reducing inappropriate prescribing for older adults with advanced frailty: A review based on a survey of practice in four countries. Maturitas. 126. 1–10. 7 indexed citations
3.
Ó’Caoimh, Rónán, Nicola Cornally, Elizabeth Weathers, et al.. (2015). Risk prediction in the community: A systematic review of case-finding instruments that predict adverse healthcare outcomes in community-dwelling older adults. Maturitas. 82(1). 3–21. 67 indexed citations
4.
Clarnette, Roger, Joseph P. Ryan, Eileen O’Herlihy, et al.. (2015). THE COMMUNITY ASSESSMENT OF RISK INSTRUMENT: INVESTIGATION OF INTER-RATER RELIABILITY OF AN INSTRUMENT MEASURING RISK OF ADVERSE OUTCOM. The Journal of Frailty & Aging. 4(2). 1–10. 7 indexed citations
5.
Ó’Caoimh, Rónán, Carol Fitzgerald, Emer O’Connell, et al.. (2014). Risk Instrument for Screening in the Community (RISC): Predicting Adverse Outcomes in Older Adults. Irish Journal of Medical Science (1971 -). 183(7). 4 indexed citations
6.
Bruce, David, Wendy A. Davis, Roger Clarnette, et al.. (2009). Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study. Diabetologia. 52(9). 1808–1815. 146 indexed citations
7.
Bruce, David, Wendy A. Davis, Sergio Starkstein, et al.. (2007). Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia. 51(2). 241–248. 113 indexed citations
8.
Foster, Jonathan K., Roger Clarnette, S. A. Paul Chubb, et al.. (2006). Interaction between Testosterone and Apolipoprotein E ε4 Status on Cognition in Healthy Older Men. The Journal of Clinical Endocrinology & Metabolism. 91(3). 1168–1172. 37 indexed citations
9.
Brodaty, Henry, David Ames, John Snowdon, et al.. (2005). Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial. International Journal of Geriatric Psychiatry. 20(12). 1153–1157. 32 indexed citations
10.
Brodaty, Henry, David Ames, John Snowdon, et al.. (2003). A Randomized Placebo-Controlled Trial of Risperidone for the Treatment of Aggression, Agitation, and Psychosis of Dementia. The Journal of Clinical Psychiatry. 64(2). 134–143. 348 indexed citations
11.
Laws, Simon M., Roger Clarnette, Kevin Taddei, et al.. (2002). Association between the presenilin-1 mutation Glu318Gly and complaints of memory impairment. Neurobiology of Aging. 23(1). 55–58. 8 indexed citations
12.
Taddei, Kevin, Christopher Fisher, Simon M. Laws, et al.. (2002). Association between presenilin-1 Glu318Gly mutation and familial Alzheimer's disease in the Australian population. Molecular Psychiatry. 7(7). 776–781. 24 indexed citations
13.
Laws, Simon M., Roger Clarnette, Kevin Taddei, et al.. (2002). APOE-ε4 and APOE −491A polymorphisms in individuals with subjective memory loss. Molecular Psychiatry. 7(7). 768–775. 52 indexed citations
14.
Laws, Simon M., Kevin Taddei, Georgia Martins, et al.. (1999). The —491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimerʼs disease. Neuroreport. 10(4). 879–882. 63 indexed citations
15.
Laws, Simon M., Kevin Taddei, Chris Fisher, et al.. (1999). Evidence that the butyryl-cholinesterase K variant can protect against late-onset Alzheimer's disease. UWA Profiles and Research Repository (University of Western Australia). 2(4). 219–223. 10 indexed citations
16.
Taddei, Kevin, Dong Won Yang, Christopher Fisher, et al.. (1998). No association of Presenilin-1 intronic polymorphism and Alzheimer's disease in Australia. Neuroscience Letters. 246(3). 178–180. 9 indexed citations
17.
Kneebone, Ian, et al.. (1997). The Dysfunctional Behaviour Rating Instrument: Utility in an Australian Population. Australian Journal on Ageing. 16(4). 208–210. 2 indexed citations
18.
Taddei, Kevin, Roger Clarnette, Sam Gandy, & Ralph N. Martins. (1997). Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease. Neuroscience Letters. 223(1). 29–32. 87 indexed citations
19.
Molloy, D. William, et al.. (1991). Clinical Significance of Primitive Reflexes in Alzheimer's Disease. Journal of the American Geriatrics Society. 39(12). 1160–1163. 21 indexed citations
20.
Molloy, D. William, et al.. (1991). Decision Making in the Incompetent Elderly: “The Daughter from California Syndrome”*. Journal of the American Geriatrics Society. 39(4). 396–399. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ann Marie Hake Breakdown of academic impact, for papers by M.‐X. Tang Breakdown of academic impact, for papers by Miranda G. Dik Breakdown of academic impact, for papers by Huang Changquan Breakdown of academic impact, for papers by Olivier Rouaud Breakdown of academic impact, for papers by Asenath La Rue Breakdown of academic impact, for papers by Kornelia Kędziora–Kornatowska Breakdown of academic impact, for papers by Anna Rita Atti Breakdown of academic impact, for papers by Antonio Capurso Breakdown of academic impact, for papers by Zaldy S. Tan
Rankless by CCL
2026